欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1608/004
药品名称
Everolimus Teva
活性成分
Everolimus 10.0 mg
剂型
Tablet
上市许可持有人
Teva Sweden AB Box 1070 251 10 Helsingborg Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Germany (DE)
Everolimus-ratiopharm 10 mg Tabletten
Denmark (DK)
Netherlands (NL)
United Kingdom (Northern Ireland) (XI)
Austria (AT)
Everolimus ratiopharm 10 mg Tabletten
France (FR)
Portugal (PT)
Greece (GR)
EVEROLIMUS/TEVA
Norway (NO)
Everolimus Teva
Latvia (LV)
Everolimus Teva 10 mg tabletes
Bulgaria (BG)
Everolimus Teva
Czechia (CZ)
Everolimus Teva 10 mg tablety
Slovakia (SK)
Everolimus Teva 10 mg
Croatia (HR)
Everolimus Pliva 10 mg tablete
许可日期
2017/05/03
最近更新日期
2024/09/19
药物ATC编码
L01EG02 everolimus
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_1608_004_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_1608_004_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_1608_004_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_1608_004_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase